Very slow growth forcast for pharma in U.S. in 2009

The U.S. pharmaceutical market is slow-growth for 2009, according to IMS Health. The company forecasts a tiny 1-2% growth rate for the next year. The data point comes from IMS’s annual Global Pharmaceutical and Therapy Forecast.   The U.S. market for pharmaceuticals will be worth about $300 bn in 2009.   What’s slowing growth prospects […]

Read full story Comments { 0 }

Moving up the health care value chain: J&J in health services

Johnson & Johnson (J&J) has acquired the online health coaching company, HealthMedia. This will move the health supply company up the health care value chain further into the provision of health services. Nine years ago, I teamed with a Big Pharma on a scenario planning exercise about consumers and health care. One of our scenarios […]

Read full story Comments { 0 }

À la carte health care: Americans are value shoppers

“The health care buffet is over,” according to Christopher Parks of change:healthcare, who spoke at last week’s Health 2.0 Conference. There’s evidence that Americans have been adapting to an à la carte health world. While there actually is a company called à la carte health care, part of Allianz, the global insurance company, I’m not […]

Read full story Comments { 0 }

Physician group practices' costs exceed revenue; primary care is hit hard

The increasing cost trends of drug supplies, staffing, and liability have driven up costs for medical group practices above revenues they collected in 2007. Primary care groups were especially hit by practice costs exceeding revenues. The revenue side is simple: declining reimbursements have hit most group practices. Overall, multispecialty group practices saw a 5.5% increase […]

Read full story Comments { 0 }

Participatory health — personal reflections on the 3rd Health 2.0 conference

I’ve returned from a week of Health 2.0 immersion on the west coast. The top-line finding: we’ve entered the period we can call Participatory Medicine. For some, like the pioneering Gilles Friedman of ACOR, this is nothing new. Other people have never heard of it. It’s global. It’s local. It’s a movement and a verb, […]

Read full story Comments { 0 }